IUD After Giving Birth: Timing, Types and Breastfeeding Safety

• A copper or hormonal IUD can be placed within 10 minutes of delivering the placenta, within 48 hours, or from about 6 weeks postpartum, all are valid and supported by WHO and FOGSI.
• Both the copper IUD (Cu-T 380A, Multiload) and the hormonal IUS (Mirena, Eloira) are safe during breastfeeding and do not reduce your milk supply.
• Immediate post-placental insertion is convenient and free under India's PPIUCD programme, but expulsion is more common (about 10 to 20 percent) than with insertion at 6 weeks (about 2 to 5 percent).
• Check your strings monthly for the first 3 to 6 months and attend the 6-week postnatal visit so your provider can confirm the device is in place.
• The copper IUD tends to make periods heavier; the hormonal IUS makes them lighter, often an advantage when postpartum iron stores are already low.
• If you cannot feel the strings, feel the device, or notice unusual pain or bleeding, use condoms as backup and see your gynaecologist.

You do not have to wait six weeks for an IUD. Over the past decade, India's maternal-health services, led by FOGSI, the Ministry of Health and Family Welfare and the National Health Mission, have expanded Postpartum Intrauterine Contraceptive Device (PPIUCD) services so that an IUD can be placed safely at the time of delivery. There are three timing windows, and each suits different situations.

Immediate post-placental insertion. The IUD is placed within 10 minutes of delivering the placenta after a vaginal birth, or during a caesarean (intra-caesarean insertion, placed by hand into the top of the uterus before it is stitched closed). You are already in the labour ward with a skilled provider, so no separate visit is needed. The uterus is large and the cervix is still open, which makes placement easy but also explains the slightly higher chance the device works its way out as the uterus shrinks. Most government facilities offer this with the free Cu-T 380A.

Early postpartum insertion. The IUD is placed between 10 minutes and 48 hours after delivery, before you go home. The pros and cons are similar to immediate insertion. It is offered in some settings but is less commonly the standard than the immediate window.

Interval insertion. The IUD is placed at about 6 weeks postpartum or later, at your routine postnatal check or a dedicated contraception visit. By then the uterus has shrunk back to roughly its pre-pregnancy size, the lochia (postpartum discharge) has settled, and you have had time to recover and think. The procedure is much like a standard IUD insertion, and expulsion is far less likely (about 2 to 5 percent in the first year). This is the usual timing for the hormonal IUS.

Which window is right for you? It depends on your preferences, where you deliver, which devices that facility stocks, whether you can return for a 6-week visit, and your overall plan. Immediate insertion is especially valuable if returning later is hard (distance, work, family demands) or you want to be sure contraception is in place before discharge. Interval insertion suits those who want a hormonal IUS, want time to decide, or deliver where immediate insertion is not offered. Many of these same questions come up if you are planning an IUD or other method after a caesarean.

Bridging with breastfeeding. If you are exclusively breastfeeding and your periods have not returned, the Lactational Amenorrhoea Method (LAM) gives reasonable protection for up to six months, provided all three conditions are met: full or near-full breastfeeding, no periods, and a baby under six months. It can bridge the gap until interval insertion. But ovulation can return before your first period, and feeding patterns often slip below the strict LAM rules, so a backup method is sensible. The IUD itself can be placed while you are still relying on LAM. See our detailed guide to contraception while breastfeeding.

The copper IUD is the most commonly placed postpartum device in India, largely because the PPIUCD programme provides the Cu-T 380A free at government facilities.

Device options. The Cu-T 380A is the standard government-distributed device, free at PHCs, CHCs, district hospitals and labour wards under the National Health Mission, and licensed for about 10 years. The Multiload Cu-375 is available in private clinics from roughly Rs 500 to 1,500 for the device, plus an insertion fee of about Rs 500 to 3,000, and lasts around 5 years depending on the variant. Both are highly effective, with fewer than 1 pregnancy per 100 women per year.

How it works. Copper ions create a mild, sterile inflammatory reaction inside the uterus that is hostile to sperm, preventing fertilisation and implantation. There is no hormone, no effect on breastfeeding, and no systemic effect on you or your baby. The same mechanism applies whether you choose copper or a hormonal IUD.

Expulsion by timing. Immediate post-placental copper IUD insertion has an expulsion rate of about 10 to 20 percent at 6 to 12 months, based on Indian PPIUCD data and international studies. Intra-caesarean placement (device tucked into the fundus by hand) tends to be lower. Interval insertion at 6 weeks or later runs about 2 to 5 percent, similar to a non-postpartum insertion. The higher early rate reflects the large uterus and open cervix at the time of placement, the device has more room to shift as the uterus shrinks.

Why string checks matter. Because expulsion can happen without you noticing, a monthly string check is important in the first 3 to 6 months after immediate insertion. You should feel the threads in the upper vagina, hanging from the cervix at about 3 to 5 cm. If you cannot feel them, contact your gynaecologist or PHC. The PPIUCD programme builds in a 6-week postnatal visit to confirm the position and trim the strings (they are deliberately left long at immediate insertion).

Periods. For non-breastfeeding women, periods usually return within 6 to 12 weeks regardless of the IUD. For breastfeeding women, return is variable, anywhere from 3 to 18 months, depending on how intensively you feed. When periods come back, copper IUD users often have heavier, crampier periods than before, because copper raises prostaglandin levels in the lining. Management is the same as for any copper IUD user: NSAIDs (mefenamic acid 500 mg three times daily, or ibuprofen 400 to 600 mg every 6 to 8 hours), tranexamic acid for heavy bleeding, and iron to prevent anaemia, which matters even more now that postpartum iron stores are already depleted. For more on the cramping pattern, see our guide to IUD cramps.

Breastfeeding. The copper IUD is fully compatible with breastfeeding, with no effect on milk supply, milk composition, or your baby. It can be placed at any timing window.

Endorsement. WHO and FOGSI explicitly support immediate post-placental, intra-caesarean and interval copper IUD insertion. The Indian PPIUCD programme has trained thousands of providers and reaches millions of postpartum insertions a year.

The levonorgestrel-releasing intrauterine system (Mirena, Eloira, Kyleena) can also be placed postpartum, though the usual timing differs from the copper IUD.

Device options. Mirena (52 mg levonorgestrel, licensed for 5 to 7 years, roughly Rs 13,000 to 18,000 plus insertion at corporate hospitals) is the original and most-studied hormonal IUS. Eloira (52 mg levonorgestrel, made in India by Pregna International, roughly Rs 8,000 to 15,000) follows the same release profile and is increasingly common in Indian private practice. Kyleena (19.5 mg, smaller frame, 5 years) is a lower-dose option that is less widely stocked here.

Timing. The hormonal IUS is usually deferred to interval insertion at 6 weeks or later. Immediate post-placental placement is technically possible but less commonly done, partly because the higher expulsion rate of the immediate window is a bigger concern when the device is costly rather than free. Interval insertion carries the usual low expulsion rate (about 2 to 5 percent).

How it works. The IUS releases levonorgestrel locally at about 20 micrograms a day (Mirena, Eloira). It thickens cervical mucus, thins the uterine lining, and partly suppresses ovulation in roughly a quarter of cycles. The local concentration is high but the amount reaching the bloodstream is small, roughly the equivalent of one progestogen-only pill every few days.

Breastfeeding. The hormonal IUS is compatible with breastfeeding. The small systemic levonorgestrel exposure does not affect milk supply, milk composition, or infant growth and development, per multiple studies. WHO, FOGSI, ACOG and RCOG all support its use while breastfeeding. The 6-week timing happens to suit both established milk supply and uterine recovery.

Periods. The hormonal IUS usually makes periods lighter and less crampy, or stops them altogether over time. By one year of Mirena use, about 20 percent of users have no periods at all, rising to about 40 percent by five years; Eloira behaves similarly. If you had heavy or painful periods before pregnancy, this can be a major improvement, and lighter periods are especially useful when postpartum iron stores are low.

Other benefits. The IUS also helps conditions such as adenomyosis, fibroids and Endometriosis Treatment in India: From NSAIDs to Excision Surgery if they affected you before pregnancy, and its 5-to-7-year action covers much of a typical pregnancy-spacing interval, with immediate fertility return on removal.

Cost in India. The IUS is a significant out-of-pocket expense (Rs 8,000 to 18,000 for the device, plus Rs 1,000 to 5,000 for insertion privately) and is generally not stocked at PHCs or CHCs, where the copper IUD is free. Some corporate insurance schemes cover it. Spread over 5 to 7 years, the per-year cost (about Rs 1,500 to 3,500) is reasonable, and savings on menstrual products, painkillers and gynaecology visits may offset part of it. For a head-to-head comparison, see copper IUD vs Mirena in India.

What insertion feels like depends on the timing window. Knowing the steps helps you prepare.

Immediate post-placental insertion (vaginal birth). The IUD is placed within 10 minutes of delivering the placenta. You are still in the labour ward and the cervix is open, so the provider uses a specialised technique (often a ring or Kelly's forceps) to place the device high in the uterine fundus. It takes a few minutes. Sensation is usually modest because you are already cramping after delivery. The strings are left long (around 10 cm) so they can be seen and trimmed at the 6-week visit.

Intra-caesarean insertion. The IUD is placed by hand into the fundus through the open uterus before it is stitched closed. It adds only minutes, and you feel nothing extra because you are already under spinal, epidural or general anaesthesia.

Early postpartum insertion (within 48 hours). Done in a procedure room before discharge, similar to immediate insertion but with the cervix slightly less open. NSAIDs (ibuprofen, mefenamic acid, or breastfeeding-friendly paracetamol) help with comfort.

Interval insertion (6 weeks or later). Done at the postnatal check or a contraception visit, much like a standard IUD insertion: speculum, a tenaculum on the cervix, a sound to measure depth, then the inserter, with strings trimmed to 3 to 5 cm. The whole thing takes 5 to 15 minutes. Taking an NSAID (ibuprofen 400 to 600 mg or mefenamic acid 500 mg) about an hour beforehand reduces pain, which is typically moderate.

Bleeding and lochia. After immediate insertion, your normal lochia continues, the IUD does not meaningfully add to it. Lochia normally lasts 4 to 6 weeks, shifting from red to brown-yellow to pale. Heavy red bleeding beyond two weeks is not normal and deserves review whether or not an IUD is in place, see our guide to postpartum bleeding and lochia. After interval insertion, expect light spotting for a few days to a few weeks.

Follow-up. The 6-week postnatal visit is the standard check after immediate or early insertion: a speculum exam confirms the device, the long strings are trimmed, and your questions are answered. For interval insertion, follow-up at 4 to 8 weeks is usual, with string checks at annual visits thereafter. The 6-week postpartum checkup is a good moment to settle your contraception plan if you have not already.

The PPIUCD programme. The Government of India has invested heavily in training providers in immediate post-placental copper IUD insertion. The programme includes ASHA-supported antenatal counselling (so you can decide before delivery), trained providers in the labour ward, 6-week follow-up at the PHC, and management of any complications, now operating across thousands of facilities.

A central question for postpartum contraception is whether it is safe while breastfeeding. Both the copper IUD and the hormonal IUS are explicitly compatible with breastfeeding per WHO Medical Eligibility Criteria, FOGSI, ACOG and RCOG. Here is what the evidence shows.

Copper IUD. No hormone is involved, so there is no transfer of any hormone, no effect on milk supply or composition, and no effect on infant growth, development or health. Copper does not enter breast milk in any meaningful amount. It can be placed at any window with no breastfeeding-related restriction.

The older concern about hormones. Combined hormonal contraceptives (which contain oestrogen and progestin) can reduce milk supply, especially when started in the first six weeks before supply is established. That is why older guidance favoured non-hormonal or progestin-only methods in early breastfeeding, and the caution was sometimes extended to the hormonal IUS by analogy.

What the evidence actually shows. The hormonal IUS releases levonorgestrel locally at about 20 micrograms a day, with only small amounts reaching the bloodstream. Multiple studies of breastfeeding women using the IUS show no clinically meaningful effect on milk supply, composition, or infant growth, weight gain, behaviour or development. WHO Medical Eligibility Criteria rate the hormonal IUS as Category 1 (no restriction) from four weeks postpartum, and Category 3 before four weeks. ACOG, RCOG and FOGSI all support its use during breastfeeding.

Why the 6-week timing fits. Interval IUS insertion at 6 weeks falls well after the four-week threshold and after milk supply is usually established, so any theoretical risk is minimal. If you prefer to wait longer, three months, six months or beyond, that is fine too.

Other progestin-only options. The progestogen-only pill (Cerazette, Cerelle), the implant (where available), and the DMPA injection are all breastfeeding-compatible, with similar safety evidence. The IUS has the advantage of very low systemic levels because it acts locally. For the full picture, see our overview of safe birth control while breastfeeding.

The bottom line. Both device types are valid choices for breastfeeding women. The decision between them comes down to your preferences, budget, expected bleeding pattern and overall plan, not to breastfeeding safety.

• You cannot feel the strings on a self-check.
• New pain or an unusual sensation in your pelvis.
• A change in bleeding pattern, such as heavier periods.
• You can see or feel the device or strings at or outside the cervix.

The IUD is one of several postpartum options. Seeing where it sits helps you choose.

Lactational Amenorrhoea Method (LAM). Exclusive breastfeeding with no periods gives reasonable protection for the first six months if all three LAM conditions are met (typical-use failure around 2 percent). It is widely used in India but ends as soon as any condition fails, so you need a longer-term plan ready.

Progestogen-only pill (POP). Breastfeeding-compatible and can start any time postpartum (typical-use failure about 9 percent a year). Must be taken daily at roughly the same time; periods are often irregular.

DMPA injection. A 3-monthly progestin injection, breastfeeding-compatible, available through the government Antara programme (typical-use failure about 4 percent a year). Periods are often absent or irregular, and fertility can take 6 to 12 months to return after stopping. See the contraceptive injection in India.

Combined hormonal methods (pill, patch, ring). Not recommended in the first six weeks postpartum and not preferred during breastfeeding because they can reduce milk supply. They become an option once you have weaned or are past 6 weeks and not breastfeeding.

Implant. The etonogestrel implant is not widely available in India but, where stocked, is breastfeeding-compatible and lasts 3 to 5 years (typical-use failure under 0.1 percent).

Condoms. Free through ASHA and government distribution, reasonable for occasional sex in the early postpartum period and the only method here that also protects against STIs (typical-use failure about 18 percent a year).

Tubal ligation. Permanent female sterilisation for those certain they want no more children; it can be done at caesarean or in the early postpartum days by mini-laparotomy under the National Family Planning programme. Best decided well after delivery. See female sterilisation options, and, for the small failure risk, pregnancy after tubal ligation.

Vasectomy. A safe, simple outpatient procedure for couples who have completed their family; no-scalpel vasectomy is free through government facilities and is often simpler and safer than tubal ligation.

Where the IUD fits. It gives 5 to 10 years of highly effective contraception, is breastfeeding-compatible in both forms, needs no daily action, is immediately reversible on removal, and ranges from free (Cu-T 380A) to Rs 13,000 to 18,000 (Mirena). It suits women who want long-term but reversible spacing, especially where daily compliance is hard.

Some postpartum circumstances change the IUD plan.

After a caesarean. The IUD can be placed by hand into the fundus through the open uterus before it is closed (intra-caesarean), adding only minutes, with no extra pain and a somewhat lower expulsion rate than after vaginal delivery. FOGSI supports this for women who decided on it during antenatal counselling.

Twins or higher-order multiples. The uterus is especially large, so more shrinking is needed and immediate-insertion expulsion may be higher; interval insertion at 6 weeks is often preferred.

VBAC. A vaginal birth after caesarean does not prevent IUD insertion; the old scar does not add difficulty or risk.

Retained products or postpartum haemorrhage. If there are retained placental fragments or significant bleeding, immediate insertion is deferred until the complication is managed; interval insertion is preferred once you have recovered.

Infection at delivery. Active infection such as chorioamnionitis is a contraindication to immediate insertion. Treat the infection, recover fully, then insert at 6 weeks or later.

Delivery at a non-PPIUCD facility. If immediate insertion is not offered where you deliver, interval insertion at 6 weeks at any IUD-providing facility is straightforward.

Previous IUD experience. If a past IUD suited you, returning to the same method is reasonable. If it caused problems (heavy bleeding, expulsion), discuss whether a different device would be better.

Rapid succession of pregnancies. If pregnancies have come close together and you want a longer gap, a postpartum IUD fits well. WHO recommends at least a 24-month interval between birth and the next pregnancy for the best maternal and newborn outcomes, and the IUD reliably covers that and beyond.

End of your reproductive plans. If this may be your last delivery, discuss both IUD and sterilisation. Some women start with an IUD and switch to sterilisation later if they stay certain.

Specific medical conditions. Severe heart disease, bleeding disorders, cavity-distorting fibroids, certain cancers and current pelvic infection may be contraindications or precautions, guided by WHO Medical Eligibility Criteria, FOGSI and your gynaecologist. Most common conditions, including diabetes, hypertension, asthma and thyroid disease, are not contraindications to IUD use.

• WHO — Medical Eligibility Criteria for Contraceptive Use (5th edition)
• Ministry of Health and Family Welfare / NHM — PPIUCD Reference Manual for Medical Officers
• ACOG — Postpartum Contraception (Committee Opinion / Clinical Guidance)
• RCOG / FSRH — Contraception After Pregnancy Guideline
• WHO — Report of a WHO technical consultation on birth spacing